Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6,826.00
Bid: 6,826.00
Ask: 6,827.00
Change: 32.00 (0.47%)
Spread: 1.00 (0.01%)
Open: 6,779.00
High: 6,873.00
Low: 6,761.00
Yest. Close: 6,794.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

LIVE MARKETS-Boohoo: the big fall from grace

* European shares slip* Wall Street rose overnight* UK's Sunak maps out next moves in recovery plan Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts Joice ...

8 Jul 20 15:12

LIVE MARKETS-EU recovery fund? Green is better

* European shares slip* Wall Street rose overnight* UK's Sunak maps out next moves in recovery plan Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts Joice ...

8 Jul 20 14:45

LIVE MARKETS-Car industry: Better be selective

* European shares slip* Wall Street rose overnight* UK's Sunak to map out next moves in recovery plan Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts Joic...

8 Jul 20 12:28

LIVE MARKETS-Goodbye Mr Bond

* European shares slip* Wall Street rose overnight* UK's Sunak to map out next moves in recovery plan Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts Joic...

8 Jul 20 10:51

LIVE MARKETS-Sunak's time to impress

* European shares slips* Wall Street rose overnight* UK's Sunak to map out next moves in recovery plan Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts Joi...

8 Jul 20 10:12

MORNING BID-Asking for more stimulus?

* A look at the day ahead from EMEA deputy markets editor Sujata Rao. The views expressed are her ownLONDON, July 8 (Reuters) - Share markets are wavering after snapping a five-day winning streak on Tuesday when world stocks tumbled 1% and all th...

8 Jul 20 09:04

LIVE MARKETS-Opening snapshot: wait and see mood

* European shares slips* Wall Street rose overnight* UK's Sunak to map out next moves in recovery plan Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts Joi...

8 Jul 20 08:58

TOP NEWS: AstraZeneca Notes EU Lynparza Approval For Pancreatic Cancer

TOP NEWS: AstraZeneca Notes EU Lynparza Approval For Pancreatic Cancer

8 Jul 20 08:30

LONDON BRIEFING: UK's Sunak To Unveil GBP2 Billion Unemployment Scheme

LONDON BRIEFING: UK's Sunak To Unveil GBP2 Billion Unemployment Scheme

8 Jul 20 07:54

LIVE MARKETS-On the radar: insurers, Boohoo, AstraZeneca, Merck

* European futures in negative territory* Wall Street rose overnight Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts Joice Alves (joice.alves@thomsonreute...

8 Jul 20 07:52

LONDON MARKET PRE-OPEN: boohoo Launches UK Supply Chain Review

LONDON MARKET PRE-OPEN: boohoo Launches UK Supply Chain Review

8 Jul 20 07:43

AstraZeneca gets EU approval for Lynparza

(Sharecast News) - AstraZeneca announced on Wednesday, alongside its partner MSD, that 'Lynparza', or olaparib, has been approved in the European Union for patients with germline BRCA-mutated (gBRCAm) metastatic pancreatic cancer.

8 Jul 20 07:18

Catalent plant in Italy will help produce J&J's potential COVID-19 vaccine - minister

ROME, July 6 (Reuters) - A plant in Italy owned by U.S. group Catalent will help produce the potential COVID-19 vaccine being developed by drugmaker Johnson & Johnson, Italian Health minister Roberto Speranza said on Monday."It is today's news tha...

6 Jul 20 17:19

China's SinoVac starts late stage trials for its COVID-19 vaccine

LONDON/BEIJING, July 6 (Reuters) - China's SinoVac is starting Phase III trials of its potential coronavirus vaccine, it said on Monday, becoming one of three companies to move into the late stages in the race to develop an inoculation against th...

6 Jul 20 14:35

UPDATE 1-Emergent signs 5-yr deal backing J&J COVID-19 vaccine

(Adds details on deal, company's other production agreements)July 6 (Reuters) - Emergent BioSolutions Inc said on Monday it had signed a five-year pact to make the drug substance used in Johnson & Johnson's COVID-19 vaccine candidate, adding to a ...

6 Jul 20 12:39

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.